Evotec SE Statistics
Total Valuation
Evotec SE has a market cap or net worth of $1.29 billion. The enterprise value is $1.34 billion.
Important Dates
The last earnings date was Thursday, April 17, 2025, before market open.
| Earnings Date | Apr 17, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Evotec SE has 177.39 million shares outstanding. The number of shares has increased by 0.21% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 177.39M |
| Shares Change (YoY) | +0.21% |
| Shares Change (QoQ) | +0.00% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 129.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.57 |
| Forward PS | 1.47 |
| PB Ratio | 1.31 |
| P/TBV Ratio | 1.94 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 68.48 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.62 |
| EV / EBITDA | 1,988.40 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.98, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.98 |
| Quick Ratio | 1.74 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 19.81 |
| Debt / FCF | n/a |
| Interest Coverage | -6.75 |
Financial Efficiency
Return on equity (ROE) is -18.92% and return on invested capital (ROIC) is -3.14%.
| Return on Equity (ROE) | -18.92% |
| Return on Assets (ROA) | -2.37% |
| Return on Invested Capital (ROIC) | -3.14% |
| Return on Capital Employed (ROCE) | -5.03% |
| Revenue Per Employee | $163,032 |
| Profits Per Employee | -$40,111 |
| Employee Count | 5,061 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 22.00 |
Taxes
In the past 12 months, Evotec SE has paid $2.18 million in taxes.
| Income Tax | 2.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -48.79% in the last 52 weeks. The beta is 1.09, so Evotec SE's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -48.79% |
| 50-Day Moving Average | 3.77 |
| 200-Day Moving Average | 4.02 |
| Relative Strength Index (RSI) | 56.15 |
| Average Volume (20 Days) | 101,254 |
Short Selling Information
| Short Interest | 806,256 |
| Short Previous Month | 723,757 |
| Short % of Shares Out | 0.26% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.14 |
Income Statement
In the last 12 months, Evotec SE had revenue of $825.10 million and -$203.00 million in losses. Loss per share was -$1.15.
| Revenue | 825.10M |
| Gross Profit | 118.94M |
| Operating Income | -81.71M |
| Pretax Income | n/a |
| Net Income | -203.00M |
| EBITDA | 673,983 |
| EBIT | -81.71M |
| Loss Per Share | -$1.15 |
Full Income StatementBalance Sheet
The company has $410.81 million in cash and $454.93 million in debt, giving a net cash position of -$44.12 million or -$0.25 per share.
| Cash & Cash Equivalents | 410.81M |
| Total Debt | 454.93M |
| Net Cash | -44.12M |
| Net Cash Per Share | -$0.25 |
| Equity (Book Value) | 986.15M |
| Book Value Per Share | 5.56 |
| Working Capital | 349.29M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $18.86 million and capital expenditures -$121.62 million, giving a free cash flow of -$112.87 million.
| Operating Cash Flow | 18.86M |
| Capital Expenditures | -121.62M |
| Free Cash Flow | -112.87M |
| FCF Per Share | -$0.64 |
Full Cash Flow StatementMargins
Gross margin is 14.41%, with operating and profit margins of -9.90% and -24.60%.
| Gross Margin | 14.41% |
| Operating Margin | -9.90% |
| Pretax Margin | -24.34% |
| Profit Margin | -24.60% |
| EBITDA Margin | 0.08% |
| EBIT Margin | -9.90% |
| FCF Margin | n/a |
Dividends & Yields
Evotec SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.21% |
| Shareholder Yield | n/a |
| Earnings Yield | -15.72% |
| FCF Yield | -8.74% |
Dividend DetailsAnalyst Forecast
The average price target for Evotec SE is $5.90, which is 64.35% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.90 |
| Price Target Difference | 64.35% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 9.90% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on October 20, 2021. It was a forward split with a ratio of 4:1.
| Last Split Date | Oct 20, 2021 |
| Split Type | Forward |
| Split Ratio | 4:1 |
Scores
Evotec SE has an Altman Z-Score of 1.1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 5 |